Modulation of the activation of Stat1 by the interferon-gamma receptor complex

Cell Research

Volumn 16, Issue 1, 2006, Pages 113-123

  Krause, Christopher D ^a   He, Wen ^a   Kotenko, Sergei ^b   Pestka, Sidney ^a,c,d  

^a RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^b RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^c RUTGERS CANCER INSTITUTE OF NEW JERSEY   (United States)

^d PBL InterferonSource   (United States)

Author keywords

Electrophoretic mobility shift assay; Interferon gamma; Interferon gamma receptor; Kinetics; Stat1

Indexed keywords

GAMMA INTERFERON; GAMMA INTERFERON RECEPTOR; INTERFERON RECEPTOR; STAT1 PROTEIN; TRANSACTIVATOR PROTEIN;

ARTICLE; CELL LINE; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; HELA CELL; HUMAN; METABOLISM; PHYSIOLOGY; SIGNAL TRANSDUCTION;

CELL LINE; GENE EXPRESSION REGULATION; HELA CELLS; HUMANS; INTERFERON TYPE II; RECEPTORS, INTERFERON; SIGNAL TRANSDUCTION; STAT1 TRANSCRIPTION FACTOR; TRANS-ACTIVATORS; TRANSCRIPTION, GENETIC; TRANSFECTION;

EID: 31144432757     PISSN: 10010602     EISSN: 17487838     Source Type: Journal    
DOI: 10.1038/sj.cr.7310015     Document Type: Article

References (93)

1. Marsters SA, Pennica D, Bach E, et al. Interferon γ signals via a high-affinity multisubunit receptor complex that contains two types of polypeptide chain. Proc Natl Acad Sci USA 1995; 92:5401-5.
2. Pestka S, Kotenko SV, Muthukumaran G, et al. The interferon γ (IFN-γ) receptor: a paradigm for the multichain cytokine receptor. Cytokine Growth Factor Rev 1997; 8:189-206.
3. Krause CD, Mei E, Xie J, et al. Seeing the light: preassembly and ligand-induced changes of the interferon γ receptor complex in cells. Mol Cell Proteomics 2002; 1:805-15.
4. Igarashi K, Garotta G, Ozmen L, et al. Interferon-γ induces tyrosine phosphorylation of interferon-γ receptor and regulated association of protein tyrosine kinases, Jak1 and Jak2, with its receptor. J Biol Chem 1994; 269:14333-6.
5. Sakatsume M, Igarashi K, Winestock KD, et al. The Jak kinases differentially associate with the αand β(accessory factor) chains of the interferon γ receptor to form a functional receptor capable of activating STAT transcription factors. J Biol Chem 1995; 270:17528-34.
6. Kotenko SV, Izotova LS, Pollack BP, et al. Interaction between the components of the interferon γ receptor complex. J Biol Chem 1995; 270:20915-21.
7. Greenlund AC, Farrar MA, Viviano BL, et al. Ligand-induced IFN γ receptor tyrosine phosphorylation couples the receptor to its signal transduction system (p91). EMBO J 1994; 13:1591-600.
8. Qing Y, Costa-Pereira AP, Watling D, et al. Role of tyrosine 441 of interferon-γ receptor subunit 1 in SOCS-1-mediated attenuation of STAT1 activation. J Biol Chem 2005; 280:1849-53.
9. Gil MP, Bonn E, O'Guin AK, et al. Biologic consequences of Stal1 -independent IFN signaling. Proc Natl Acad Sci U S A 2001; 98:6680-5.
10. Ramana CV, Gil MP, Han Y, et al. Stal1-independent regulation of gene expression in response to IFN-γ. Proc Natl Acad Sci U S A 2001; 98:6674-9.
11. Song MM, Shuai K. The suppressor of cytokine signaling (SOCS) 1 and SOCS3 but not SOCS2 proteins inhibit interferon-medialed antiviral and antiproliferative activities. J Biol Chem 1998; 273:35056-62.
12. Haspel RL, Salditt-Georgieff M, Darnell JE Jr. The rapid inactivation of nuclear tyrosine phosphorylated Stat1 depends upon a protein tyrosine phosphatase. EMBO J 1996; 15:6262-8.
13. You M, Yu DH, Feng GS. Shp-2 tyrosine phosphatase functions as a negative regulator of the interferon-stimulated Jak/STAT pathway. Mol Cell Biol 1999; 19:2416-24.
14. Myers MP, Andersen JN, Cheng A, et al. TYK2 and JAK2 are substrates of protein tyrosine phosphatase 1B. J Biol Chem 2001; 276:47771-4.
15. Liu B, Liao J, Rao X, et al. Inhibition of Stat1-mediated gene activation by PIAS1. Proc Natl Acad Sci U S A 1998; 95:10626-31.
16. Starr R, Hilton DJ. Negative regulation of the JAK/STAT pathway. Bioessays 1999; 21:47-52.
17. Sakamoto H, Kinjyo I, Yoshimura A. The janus kinase inhibitor, Jab/SOCS-1, is an interferon-γ inducible gene and determines the sensitivity to interferons. Leuk Lymphoma 2000; 38:49-58.
18. Saito H, Morita Y, Fujimoto M, et al. IFN regulatory factor-1-mediated transcriptional activation of mouse STAT-induced STAT inhibitor-1 gene promoter by IFN-γ. J Immunol 2000; 164:5833-43.
19. Endo TA, Masuhara M, Yokouchi M, et al. A new protein containing an SH2 domain that inhibits JAK kinases. Nature 1997; 387:921-4.
20. Pine R, Canova A, Schindler C. Tyrosine phosphorylated p91 binds to a single element in the ISGF2/IRF-1 promoter to mediate induction by IFN α and IFN γ, and is likely to autoregulate the p91 gene. EMBO J 1994; 13:158-67.
21. Hobart M, Ramassar V, Goes N, et al. The induction of class I and II major histocompatibility complex by allogeneic stimulation is dependent on the transcription factor interferon regulatory factor 1 (IRF-1): observations in IRF-1 knockout mice. Transplantation 1996; 62:1895-901.
22. Chow WA, Fang JJ, Yee JK. The IFN regulatory factor family participates in regulation of Fas ligand gene expression in T cells. J Immunol 2000; 164:3512-8.
23. Kim EJ, Lee JM, Namkoong SE, et al. Interferon regulatory factor-1 mediates interferon-γ-induced apoptosis in ovarian carcinoma cells. J Cell Biochem 2002; 85:369-80.
24. Ruiz-Ruiz C, Ruiz de Almodovar C, Rodriguez A, et al. The up-regulation of human caspase-8 by interferon-γ in breast tumor cells requires the induction and action of the transcription factor interferon regulatory factor-1. J Biol Chem 2004; 279:19712-20.
25. Collart MA, Belin D, Vassalli JD, et al. γ interferon enhances macrophage transcription of the tumor necrosis factor/cachectin, interleukin 1, and urokinase genes, which are controlled by short-lived repressors. J Exp Med 1986; 164:2113-8.
26. Tsujimoto M, Yip YK, Vilcek J. Interferon-γ enhances expression of cellular receptors for tumor necrosis factor. J Immunol 1986; 136:2441-4.
27. Tsujimoto M, Vilcek J. Tumor necrosis factor receptors in HeLa cells and their regulation by interferon-γ. J Biol Chem 1986; 261:5384-8.
28. Tsujimoto M, Feinman R, Vilcek J. Differential effects of type I IFN and IFN-γ on the binding of tumor necrosis factor to receptors in two human cell lines. J Immunol 1986; 137:2272-6.
29. Ruggiero V, Tavernier J, Fiers W, et al. Induction of the synthesis of tumor necrosis factor receptors by interferon-γ. J Immunol 1986; 136:2445-50.
30. Pandita R, Pocsik E, Aggarwal BB. Interferon-γ induces cell surface expression for both types of tumor necrosis factor receptors. FEBS Lett 1992; 312:87-90.
31. Ossina NK, Cannas A, Powers VC, et al. Interferon-γ modulates a p53-independent apoptotic pathway and apoptosis-related gene expression. J Biol Chem 1997; 272:16351-7.
32. Kumar A, Commane M, Flickinger TW, et al. Defective TNF-α-induced apoptosis in STAT1-null cells due to low constitutive levels of caspases. Science 1997; 278:1630-2.
33. Xu X, Fu XY, Plate J, et al. IFN-γ induces cell growth inhibition by Fas-mediated apoptosis: requirement of STAT1 protein for up-regulation of Fas and FasL expression. Cancer Res 1998; 58:2832-7.
34. Shustov A, Nguyen P, Finkelman F, et al. Differential expression of Fas and Fas ligand in acute and chronic graft-versus-host disease: up-regulation of Fas and Fas ligand requires CD8+ T cell activation and IFN-γ production. J Immunol 1998; 161:2848-55.
35. Sedger LM, Shows DM, Blanton RA, et al. IFN-γ mediates a novel antiviral activity through dynamic modulation of TRAIL and TRAIL receptor expression. J Immunol 1999; 163:920-6.
36. Chin YE, Kitagawa M, Kuida K, et al. Activation of the STAT signaling pathway can cause expression of caspase 1 and apoptosis. Mol Cell Biol 1997; 17:5328-37.
37. Dai C, Krantz SB. Interferon γ induces upregulation and activation of caspases 1, 3, and 8 to produce apoptosis in human erythroid progenitor cells. Blood 1999; 93:3309-16.
38. Fulda S, Debatin KM. IFNγ sensitizes for apoptosis by upregulating caspase-8 expression through the Stat1 pathway. Oncogene 2002; 21:2295-308.
39. Chon SY, Hassanain HH, Gupta SL. Cooperative role of interferon regulatory factor 1 and p91 (STAT1) response elements in interferon-γ- inducible expression of human indoleamine 2,3-dioxygenase gene. J Biol Chem 1996; 271:17247-52.
40. Boehm U, Klamp T, Groot M, et al. Cellular responses to interferon-γ. Annu Rev Immunol 1997; 15:749-95.
41. Barber GN. The interferons and cell death: guardians of the cell or accomplices of apoptosis? Semin Cancer Biol 2000; 10:103-11.
42. Schroder K, Hertzog PJ, Ravasi T, et al. Interferon-γ: an overview of signals, mechanisms and functions. J Leukoc Biol 2004; 75:163-89.
43. Buschle M, Campana D, Carding SR, et al. Interferon γ inhibits apoptotic cell death in B cell chronic lymphocytic leukemia. J Exp Med 1993; 177:213-8.
44. Yong VW, Moumdjian R, Yong FP, et al. γ-interferon promotes proliferation of adult human astrocytes in vitro and reactive gliosis in the adult mouse brain in vivo. Proc Natl Acad Sci U S A 1991; 88:7016-20.
45. Novelli F, Bernabei P, Ozmen L, et al. Switching on of the proliferation or apoptosis of activated human T lymphocytes by IFN-γ is correlated with the differential expression of the α- and β-chains of its receptor. J Immunology 1996; 157:1935-43.
46. Novelli F, D'Elios MM, Bernabei P, et al. Expression and role in apoptosis of the α- and β-chains of the IFN-γ receptor on human Th1 and Th2 clones. J Immunol 1997; 159:206-13.
47. Drexler HG, Zaborski M, Quentmeier H. Interferon-γ induced proliferation of human myeloid leukaemia cell lines. Br J Haematol 1997; 98:699-710.
48. Rubio N, Torres C. Interferon-γ induces proliferation but not apoptosis in murine astrocytes through the differential expression of the myc proto-oncogene family. Brain Res Mol Brain Res 1999; 71:104-10.
49. Asao H, Fu XY. Interferon-γ has dual potentials in inhibiting or promoting cell proliferation. J Biol Chem 2000; 275:867-74.
50. Bernabei P, Coccia EM, Rigamonti L, et al. Interferon-γ receptor 2 expression as the deciding factor in human T, B, and myeloid cell proliferation or death. J Leukoc Biol 2001; 70:950-60.
51. Costa-Pereira AP, Tininini S, Strobl B, et al. Mutational switch of an IL-6 response to an interferon-γ-like response. Proc Natl Acad Sci U S A 2002; 99:8043-7.
52. Orchansky P, Rubinstein M, Fischer DG. The interferon-γ receptor in human monocytes is different from the one in nonhematopoietic cells. J Immunol 1986; 136:169-73.
53. Fischer DG, Novick D, Orchansky P, et al. Two molecular forms of the human interferon-γ receptor. Ligand binding, internalization, and down-regulation. J Biol Chem 1988; 263:2632-7.
54. Novelli F, Di Pierro F, Francia di Celle P, et al. Environmental signals influencing expression of the IFN-γ receptor on human T cells control whether IFN-γ promotes proliferation or apoptosis. J Immunology 1994; 152:496-504.
55. H1 cells. Science 1995; 269:245-7.
56. Bach EA, Szabo SJ, Dighe AS, et al. Ligand-induced autoregulation of IFN-γ receptor β chain expression in T helper cell subsets. Science 1995; 270:1215-8.
57. Skrenta H, Peritt D, Cook JR, et al. The expression of the second interferon γ receptor chain (IFN-γR2) distinguishes human cytotoxic (CD8+) as well as helper (CD4+) T-cell subsets. Eur Cytokine Net 1996; 7:622.
58. Sakatsume M, Finbloom DS. Modulation of the expression of the IFN-γ receptor β-chain controls responsiveness to IFN-γ in human peripheral blood T cells. J Immunol 1996; 156:4160-6.
59. Groux H, Sornasse T, Cottrez F, et al. Induction of human T helper cell type 1 differentiation results in loss of IFN-γ receptor β-chain expression. J Immunol 1997; 158:5627-31.
60. Kung H, Pan YE, Moschera J, et al. Purification of recombinant human immune interferon. Meth In Enzym 1986; 119:204-10.
61. Kotenko SV, Izotova LS, Pollack BP, et al. Other kinases can substitute for Jak2 in signal transduction by interferon-γ. J Biol Chem 1996; 271:17174-82.
62. Kotenko SV, Krause CD, Izotova LS, et al. Identification and characterization of a second chain of the interleukin-10 receptor complex. EMBO J 1997; 16:5894-903.
63. Kotenko SV, Izotova LS, Mirochnitchenko OV, et al. The intracellular domain of interferon-α receptor 2c (IFN-αR2c) chain is responsible for Stat activation. Proc Natl Acad Sci U S A 1999; 96:5007-12.
64. Garotta G, Ozmen L, Fountoulakis M, et al. Human interferon-γ receptor. Mapping of epitopes recognized by neutralizing antibodies using native and recombinant receptor proteins. J Biol Chem 1990; 265:6908-15.
65. Livnah O, Johnson DL, Stura EA, et al. An antagonist peptide-EPO receptor complex suggests that receptor dimerization is not sufficient for activation. Nat Struct Bio 1998; 5:993-1004.
66. Krause CD, Lunn CA, Izotova LS, et al. Studies on signaling of covalent heterodimers of interferon-γ: evidence for one-sided signaling in the active tetrameric receptor complex. J Biol Chem 2000; 275:22995-3004.
67. Dignam JD, Lebovitz RM, Roeder RG. Accurate transcription initiation by RNA polymerase II in a soluble extract isolated mammalian nuclei. Nuc Acids Res 1983; 11:1475-89.
68. Swillins S, Cochaux P, Lecocq R. A pitfall in the computer-aided quantification of autoradiograms. Trends in Bioch Sci 1989; 14:440-1.
69. Kile BT, Nicola NA, Alexander WS. Negative regulators of cytokine signaling. Int J Hematol 2001; 73:292-8.
70. Chen W, Daines MO, Khurana Hershey GK. Turning off signal transducer and activator of transcription (STAT): the negative regulation of STAT signaling. J Allergy Clin Immunol 2004; 114:476-89.
71. Bai L, Merchant JL. Transcription factor ZBP-89 is required for STAT1 constitutive expression. Nucleic Acids Res 2003; 31:7264-70.
72. Parisien JP, Lau JF, Rodriguez JJ, et al. Selective STAT protein degradation induced by paramyxoviruses requires both STAT1 and STAT2 but is independent of α/β interferon signal transduction. J Virol 2002; 76:4190-8.
73. Hendry L, John S. Regulation of STAT signalling by proteolytic processing. Eur J Biochem 2004; 271:4613-20.
74. Rogers RS, Horvath CM, Matunis MJ. SUMO modification of STAT1 and its role in PIAS-mediated inhibition of gene activation. J Biol Chem 2003; 278:30091-7.
75. Ungureanu D, Vanhatupa S, Kotaja N, et al. PIAS proteins promote SUMO-1 conjugation to STAT1. Blood 2003; 102:3311-3.
76. Liu B, Mink S, Wong KA, et al. PIAS1 selectively inhibits interferon-inducible genes and is important in innate immunity. Nat Immunol 2004; 5:891-8.
77. Eilers A, Georgellis D, Klose B, et al. Differentiation-regulated serine phosphorylation of STAT1 promotes GAF activation in macrophages. Mol Cell Biol 1995; 15:3579-86.
78. Eilers A, Decker T. Activity of Stat family transcription factors is developmentally controlled in cells of the macrophage lineage. Immunobiology 1995; 193:328-33.
79. McDowell MA, Lucas DM, Nicolet CM, et al. Differential utilization of IFN-γ-responsive elements in two maturationally distinct macrophage cell lines. J Immunol 1995; 155:4933-8.
80. Lucas DM, Lokuta MA, McDowell MA, et al. Analysis of the IFN-γ-signaling pathway in macrophages at different stages of maturation. J Immunol 1998; 160:4337-42.
81. Köster M, Hauser H. Dynamic redistribution of STAT1 protein in IFN signaling visualized by GFP fusion proteins. Eur J Biochem 1999; 260:137-44.
82. Quirk SM, Cowan RG, Huber SH. Fas antigen-mediated apoptosis of ovarian surface epithelial cells. Endocrinology 1997; 138:4558-66.
83. Rhee S, Ebensperger C, Dembic Z, et al. The structure of the gene for the second chain of the human interferon-γ receptor. J Biol Chem 1996; 271:28947-52.
84. Ebensperger C, Rhee S, Muthukumaran G, et al. Genomic organization and promoter analysis of the gene ifngr2 encoding the second chain of the mouse interferon-γ receptor. Scand J Immunol 1996; 44:599-606.
85. Skrenta H, Yang Y, Pestka S, et al. Ligand-independent down-regulation of IFN-γ receptor 1 following TCR engagement. J Immunol 2000; 164:3506-11.
86. Rigamonti L, Ariotti S, Losana G, et al. Surface expression of the IFN-γR2 chain is regulated by intracellular trafficking in human T lymphocytes. J Immunol 2000; 164:201-7.
87. Bernabei P, Bosticardo M, Losana G, et al. IGF-1 down-regulates IFN-γR2 chain surface expression and desensitizes IFN-γ/STAT-1 signaling in human T lymphocytes. Blood 2003; 102:2933-9.
88. Lai D. The mapping of the murine and human interferon γ receptor. 1994;
89. Faltynek CR, Princler GL. Modulation of interferon-α and interferon-γ receptor expression during T-lymphocyte activation and proliferation. J Interferon Res 1986; 6:639-53.
90. Pestka S, Kelder B, Familletti PC, et al. Molecular weight of the functional unit of human leukocyte, fibroblast, and immune interferons. J Biol Chem 1983; 258: 9706-9.
91. Langer JA, Rashidbaigi A, Garotta G, et al. Radiation inactivation of human γ-interferon: cellular activation requires two dimers. Proc Natl Acad Sci USA 1994; 91:5818-22.
92. Takaoka A, Mitani Y, Suemori H, et al. Cross talk between interferon-γ and -α/β signaling components in caveolar membrane domains. Science 2000; 288:2357-60.
93. Krause CD, Lavnikova N, Xie J, et al. Preassembly and ligand-induced restructuring of the chains of the IFN-γ receptor complex: the roles of Jak kinases, Stat1 and the receptor chains. Cell Research 2006; 16:55-69.